Nac Akut Ratiopharm (Acetylcysteine)

Acetylcysteine, the active ingredient in Nac Akut Ratiopharm, is a mucolytic agent presented as an oral dosage form for oral use. It reduces mucus viscosity and aids expectoration in acute and chronic respiratory conditions such as bronchitis and COPD.

GNH USA supplies Nac Akut Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nac Akut Ratiopharm is a mucolytic medication used to improve clearance of respiratory secretions in several conditions.

Acute bronchitis: facilitates expectoration and eases cough by thinning airway mucus. Chronic obstructive pulmonary disease (COPD): helps reduce mucus load and improve breathing efficiency. Chronic bronchitis: supports mucus clearance and reduces frequency of productive cough episodes.

Acetylcysteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea or upset stomach. - Vomiting. - Diarrhea. - Mild abdominal discomfort. - Unpleasant taste or odor. - Skin rash or mild itching.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema). - Bronchospasm, especially in asthmatic patients. - Hepatic dysfunction or elevated liver enzymes. - Hemolytic anemia in patients with G6PD deficiency. - Persistent or worsening respiratory symptoms. - Unexplained fever or systemic signs of infection.

When using Nac Akut Ratiopharm, consider the following safety measures.

Pregnancy: consult a healthcare professional as safety data are limited. Breastfeeding: discuss potential risks with a physician before use. Asthma: monitor for bronchospasm; discontinue if symptoms worsen. G6PD deficiency: avoid use due to risk of hemolysis. Drug interactions: review concomitant medications with a pharmacist. Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Acetylcysteine may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Nitrofurantoin: concurrent use can reduce nitrofurantoin efficacy. - Activated charcoal: may decrease acetylcysteine absorption if taken simultaneously.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase risk of bronchospasm in sensitive individuals. - Certain antibiotics (e.g., carbapenems): monitor for additive gastrointestinal effects. - Inhaled bronchodilators: observe for any change in respiratory response.